UK MHRA grants CTA for first-in-human trial of a selective GPR17 antagonist Small molecule therapeutic designed for treatment of neurological diseases such as multiple sclerosis Edinburgh, UK January 14 2025 – Pheno Therapeutics Limited., a biotechnology company focused on the…
Read More